← All indications

Mixed Connective Tissue Disease

A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a speckled epidermal nuclear staining pattern on direct immunofluorescence.

Drugs by status

Phase 3 trials (2)

Phase 2 trials (1)

Organizations

Organization Involved with Phase 3 Indications (2)

Organization Involved with Other Experimental Indications (1)

ICD-10 crosswalk